From the Department of Radiology, The Ohio State University College of Medicine and Wexner Medical Center, 450 Faculty Office Tower, 395 W 12th Ave, Columbus, OH 43210
Auto-generated profile, based on publicly available information
Zarine K. Shah
From the Department of Radiology, The Ohio State University College of Medicine and Wexner Medical Center, 450 Faculty Office Tower, 395 W 12th Ave, Columbus, OH 43210
Purpose: To evaluate the capability of amide proton transfer (APT) MR imaging for detection of prostate cancer that typically shows a higher tumor cell proliferation rate and cellular density leading to an MRI‐detectable overall elevated mobile protein level in higher grade tumors.Materials and Methods: Twelve patients with biopsy‐proven prostate cancer were imaged on a 3 Tesla MR imaging system before prostatectomy. APT‐MR images were acquired by means of a single‐slice single‐shot turbo spin echo sequence with a saturation prepulse preparation using 33 different frequency offsets (−8 to 8 ppm, interval 0.5 ppm). For quantification we used the APT ratio (APTR) based on the asymmetry of the magnetization transfer ratio at 3.5 ppm in respect to the water signal. Tumor and peripheral zone benign regions of interest (ROIs) were delineated based on whole mount pathology slides after prostatectomy.Results: APTR in prostate cancer ROIs was 5.8% ± 3.2%, significantly higher than that in the peripheral zone benign regions (0.3% ± 3.2%, P = 0.002).Conclusion: APT‐MR imaging is feasible in prostate cancer detection and has the potential to discriminate between cancer and noncancer tissues. J. Magn. Reson. Imaging 2011;33:647–654.
New cross-sectional imaging feature definitions and standardized reporting recommendations for chronic pancreatitis will allow a more standardized approach to diagnosis and assessment of disease severity for clinical trials. Chronic pancreatitis is an inflammatory condition of the pancreas with clinical manifestations ranging from abdominal pain, acute pancreatitis, exocrine and/or endocrine dysfunction, and pancreatic cancer. There is a need for longitudinal studies in well-phenotyped patients to ascertain the utility of cross-sectional imaging findings of chronic pancreatitis for diagnosis and assessment of disease severity. CT and MR cholangiopancreatography are the most common cross-sectional imaging studies performed for the evaluation of chronic pancreatitis. Currently, there are no universal reporting standards for chronic pancreatitis. Several features of chronic pancreatitis are applied clinically, such as calcifications, parenchymal T1 signal changes, focal or diffuse gland atrophy, or irregular contour of the gland. Such findings have not been incorporated into standardized diagnostic criteria. There is also lack of consensus on quantification of disease severity in chronic pancreatitis, other than by using ductal ...
13 December 2007 in Journal of Gastroenterology and Hepatology
Purpose To apply k‐means clustering of two pharmacokinetic parameters derived from 3T dynamic contrast‐enhanced magnetic resonance imaging (DCE‐MRI) to predict the chemotherapeutic response in bladder cancer at the mid‐cycle timepoint. Materials and Methods With the predetermined number of three clusters, k‐means clustering was performed on nondimensionalized Amp and kep estimates of each bladder tumor. Three cluster volume fractions (VFs) were calculated for each tumor at baseline and mid‐cycle. The changes of three cluster VFs from baseline to mid‐cycle were correlated with the tumor's chemotherapeutic response. Receiver‐operating‐characteristics curve analysis was used to evaluate the performance of each cluster VF change as a biomarker of chemotherapeutic response in bladder cancer. Results The k‐means clustering partitioned each bladder tumor into cluster 1 (low kep and low Amp), cluster 2 (low kep and high Amp), cluster 3 (high kep and low Amp). The changes of all three cluster VFs were found to be associated with bladder tumor response to chemotherapy. The VF change of cluster 2 presented with the highest area‐under‐the‐curve value (0.96) and the highest sensitivity/specificity/accuracy (96%/100%/97%) with a selected cutoff value. Conclusion The k‐means clustering of the two DCE‐MRI pharmacokinetic parameters can characterize the complex microcirculatory changes within a bladder tumor to enable early prediction of the tumor's chemotherapeutic response. J. Magn. Reson. Imaging 2015;41:1374–1382.
1 January 2009 in World Journal of Gastroenterology